References
1. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on
the definition and management of anaphylaxis: summary report–Second
National Institute of Allergy and Infectious Disease/Food Allergy and
Anaphylaxis Network symposium. The Journal of allergy and clinical
immunology. 2006;117(2):391-397.
2. Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice
parameter update-2014. J Allergy Clin Immunol.2014;134(5):1016-1025.e1043.
3. Panesar SS, Javad S, de Silva D, et al. The epidemiology of
anaphylaxis in Europe: a systematic review. Allergy.2013;68(11):1353-1361.
4. Grabenhenrich LB, Dolle S, Moneret-Vautrin A, et al. Anaphylaxis in
children and adolescents: The European Anaphylaxis Registry. The
Journal of allergy and clinical immunology. 2016;137(4):1128-1137
e1121.
5. Ramsey NB, Guffey D, Anagnostou K, Coleman NE, Davis CM. Epidemiology
of Anaphylaxis in Critically Ill Children in the United States and
Canada. J Allergy Clin Immunol Pract. 2019;7(7):2241-2249.
6. Li J, Ogorodova LM, Mahesh PA, et al. Comparative Study of Food
Allergies in Children from China, India, and Russia: The
EuroPrevall-INCO Surveys. J Allergy Clin Immunol Pract.2020;8(4):1349-1358.e1316.
7. Tham EH, Leung ASY, Pacharn P, et al. Anaphylaxis – Lessons learnt
when East meets West. Pediatric Allergy and Immunology.2019;30(7):681-688.
8. Wang Y, Allen KJ, Suaini NHA, McWilliam V, Peters RL, Koplin JJ. The
global incidence and prevalence of anaphylaxis in children in the
general population: A systematic review. Allergy.2019;74(6):1063-1080.
9. Hospital Authority. Hospital Authority Annual Report 2017-2018. 2018;
http://www.ha.org.hk/ho/corpcomm/AR201718/PDF/HA_Annual_Report_2017-2018.pdf.
10. Authority H. Clusters, Hospitals & Institutions.
https://www.ha.org.hk/visitor/ha_visitor_index.asp?Content_ID=10036.
Accessed 1-Nov-2019.
11. Census and Statistics Department. Population Estimates. 2019;
https://www.censtatd.gov.hk/hkstat/sub/so150.jsp. Accessed
1-Nov-2019.
12. Turner PJ, Gowland MH, Sharma V, et al. Increase in
anaphylaxis-related hospitalizations but no increase in fatalities: an
analysis of United Kingdom national anaphylaxis data, 1992-2012. J
Allergy Clin Immunol. 2015;135(4):956-963.e951.
13. Tejedor-Alonso MA, Moro-Moro M, Mosquera González M, et al.
Increased incidence of admissions for anaphylaxis in Spain 1998-2011.Allergy. 2015;70(7):880-883.
14. Hoyos-Bachiloglu R, Morales PS, Cerda J, et al. Higher latitude and
lower solar radiation influence on anaphylaxis in Chilean children.Pediatr Allergy Immunol. 2014;25(4):338-343.
15. Lee S, Hess EP, Lohse C, Gilani W, Chamberlain AM, Campbell RL.
Trends, characteristics, and incidence of anaphylaxis in 2001-2010:
A population-based study. J Allergy Clin Immunol.2017;139(1):182-188.e182.
16. Li PH, Thomas I, Wong JC, Rutkowski K, Lau CS. Differences in
omega-5-gliadin allergy: East versus West. Asia Pac Allergy.2020;10(1):e5.
17. Lee S, Hess EP, Lohse C, Souza DL, Campbell RL. Epinephrine
Autoinjector Prescribing Trends: An Outpatient Population-Based Study in
Olmsted County, Minnesota. J Allergy Clin Immunol Pract.2016;4(6):1182-1186.e1181.
18. Parke L, Senders AS, Bindslev-Jensen C, et al. Adherence to
adrenaline autoinjector prescriptions in patients with anaphylaxis.Clin Transl Allergy. 2019;9:59.
19. Simons FE, Ardusso LR, Bilò MB, et al. World allergy organization
guidelines for the assessment and management of anaphylaxis. World
Allergy Organ J. 2011;4(2):13-37.
20. Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis
and management of food allergy in the United States: report of the
NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6
Suppl):S1-58.
21. Ewan P, Brathwaite N, Leech S, et al. BSACI guideline: prescribing
an adrenaline auto-injector. Clinical & Experimental Allergy.2016;46(10):1258-1280.
22. Lee TH, Leung TF, Wong G, et al. The unmet provision of allergy
services in Hong Kong impairs capability for allergy
prevention-implications for the Asia Pacific region. Asian Pac J
Allergy Immunol. 2019;37(1):1-8.
23. Paller AS, Spergel JM, Mina-Osorio P, Irvine AD. The atopic march
and atopic multimorbidity: Many trajectories, many pathways. J
Allergy Clin Immunol. 2019;143(1):46-55.
24. Mullins RJ. Anaphylaxis: risk factors for recurrence. Clin Exp
Allergy. 2003;33(8):1033-1040.
25. Alonso MA, Garcia MV, Hernandez JE, et al. Recurrence of anaphylaxis
in a Spanish series. J Investig Allergol Clin Immunol.2013;23(6):383-391.
26. Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. Risk
factors for recurrent anaphylaxis-related emergency department visits in
the United States. Ann Allergy Asthma Immunol.2018;121(6):717-721 e711.
27. Dorris S. Fatal food anaphylaxis: Registering a rare outcome.Ann Allergy Asthma Immunol. 2020;124(5):445-446.
28. Noimark L, Wales J, Du Toit G, et al. The use of adrenaline
autoinjectors by children and teenagers. Clinical & Experimental
Allergy. 2012;42(2):284-292.